Original language | English (US) |
---|---|
Pages (from-to) | 932-933 |
Number of pages | 2 |
Journal | The Lancet Psychiatry |
Volume | 7 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2020 |
ASJC Scopus subject areas
- Psychiatry and Mental health
- Biological Psychiatry
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Characterising neuropsychiatric disorders in patients with COVID-19. / Oldham, Mark A.; Slooter, Arjen J.C.; Cunningham, Colm; Rahman, Shibley; Davis, Daniel; Vardy, Emma R.L.C.; Garcez, Flavia B.; Neufeld, Karin J.; de Castro, Roberta Esteves Vieira; Ely, E. Wesley; MacLullich, Alasdair.
In: The Lancet Psychiatry, Vol. 7, No. 11, 11.2020, p. 932-933.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Characterising neuropsychiatric disorders in patients with COVID-19
AU - Oldham, Mark A.
AU - Slooter, Arjen J.C.
AU - Cunningham, Colm
AU - Rahman, Shibley
AU - Davis, Daniel
AU - Vardy, Emma R.L.C.
AU - Garcez, Flavia B.
AU - Neufeld, Karin J.
AU - de Castro, Roberta Esteves Vieira
AU - Ely, E. Wesley
AU - MacLullich, Alasdair
N1 - Funding Information: AJCS reports grants from Horizon2020, during the conduct of the study, and is an advisor for Prolira. CC reports grants from IONIS Pharmaceuticals, outside of the submitted work. ERLCV reports fees for travel and accommodation from MA Healthcare, fees for a course and accommodation from NHS Digital, a sponsored table at an awards ceremony from Allscripts, fees for conference attendance from the Royal College of Physicians (London) and the Royal College of Physicians (Edinburgh), and travel fees from the Scottish Delirium Association. FBG reports a research grant from the Network for Investigation of Delirium: Unifying Scientists (subaward of Federal Award R24AG054259), outside of the submitted work. KJN reports grants from Hitachi and personal fees from Merck, outside of the submitted work. EWE reports grants from the Department of Veterans Affairs/National Institutes of Health and Kohler, and personal fees from Pfizer/Orion and Masimo. AM holds US and European patents on computerised attentional tests relevant to delirium detection (Europe EP2485645B1; USA 9307940). All other authors declare no competing interests.
PY - 2020/11
Y1 - 2020/11
UR - http://www.scopus.com/inward/record.url?scp=85092629868&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092629868&partnerID=8YFLogxK
U2 - 10.1016/S2215-0366(20)30346-1
DO - 10.1016/S2215-0366(20)30346-1
M3 - Letter
C2 - 33069307
AN - SCOPUS:85092629868
VL - 7
SP - 932
EP - 933
JO - The Lancet Psychiatry
JF - The Lancet Psychiatry
SN - 2215-0366
IS - 11
ER -